Self-Service Login / Register | bluecrossnepastore.com
Powered by Google

Utilization Management Criteria

Adjust type sizesmallmediumlarge

By Drug Name:

UMC-530-0170 ABRAXANE PRIOR AUTHORIZATION CRITERIA
UMC-530-0047 ABSTRAL PRIOR AUTHORIZATION CRITERIA
UMC-530-0133 ACANYA STEP THERAPY CRITERIA
UMC-530-0027 ACIPHEX SPRINKLES STEP THERAPY CRITERIA
UMC-530-0093 ACTEMRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0147 ACTHAR H.P. GEL PRIOR AUTHORIZATION CRITERIA
UMC-530-0108 ACTICLATE PRIOR  AUTHORIZATION CRITERIA
UMC-530-0047 ACTIQ PRIOR AUTHORIZATION CRITERIA
UMC-530-0205 ADAGEN PRIOR AUTHORIZATION CRITERIA
UMC-530-0149 ADDERALL STEP THERAPY CRITERIA
UMC-530-0181 ADEMPAS PRIOR AUTHORIZATION/STEP THERAPY CRITERIA
UMC-530-0108 ADOXA PRIOR AUTHORIZATION CRITERIA
UMC-530-0089 AFINITOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0019 ALDURAZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0173 ALIMTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0108 ALODOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0206 ALOXI (PALONOSETRON) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0038 ALTOPREV STEP THERAPY CRITERIA
UMC-530-0045 ALVESCO STEP THERAPY CRITERIA
UMC-530-0098 AMPYRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0022 ANADROL-50 PRIOR AUTHORIZATION CRITERIA
UMC-530-0036 ANZEMET STEP THERAPY CRITERIA
UMC-530-0039 APRISO STEP THERAPY CRITERIA
UMC-530-0072 ARCALYST PRIOR AUTHORIZATION CRITERIA
UMC-530-0092 ARZERRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0113 AUBAGIO PRIOR AUTHORIZATION CRITERIA
UMC-530-0200 AVASTIN (bevacizumab) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0108 AVIDOXY PRIOR AUTHORIZATION CRITERIA
UMC-530-0106 AVONEX STEP THERAPY CRITERIA
UMC-530-0094 AZOR STEP PRIOR AUTHORIZATION CRITERIA
UMC-530-0044 BECONASE AQ STEP THERAPY CRITERIA
UMC-530-0081 BELSOMRA STEP THERAPY CRITERIA
UMC-530-0083 BENICAR HCT STEP THERAPY CRITERIA
UMC-530-0201 BELEODAQ PRIOR AUTHORIZATION CRITERIA
UMC-530-0082 BENICAR STEP THERAPY CRITERIA
UMC-530-0125 BENLYSTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0133 BENZACLIN STEP THERAPY CRITERIA
UMC-530-0076 BERINERT PRIOR AUTHORIZATION CRITERIA
UMC-530-0216 BLINCYTO PRIOR AUTHORIZATION CRITERIA
UMC-530-0060 BONIVA PRIOR AUTHORIZATION CRITERIA
UMC-530-0067 BOSULIF PRIOR AUTHORIZATION CRITERIA
UMC-530-0048 BOTOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0054 BRINTELLIX STEP THERAPY CRITERIA
UMC-530-0054 BRISDELLE STEP THERAPY CRITERIA
UMC-530-0214 BUPHENYL PRIOR AUTHORIZATION CRITERIA
UMC-530-0172 BUPRENORPHINE-NALOXONE PRIOR AUTHORIZATION CRITERIA
UMC-530-0130 BUTRANS PRIOR AUTHORIZATION CRITERIA
UMC-530-0052 BYDUREON STEP THERAPY CRITERIA
UMC-530-0052 BYETTA STEP THERAPY CRITERIA
UMC-530-0115 CAMBIA STEP THERAPY CRITERIA
UMC-530-0120 CAPRELSA PRIOR AUTHORIZATION CRITERIA
UMC-530-0214 CARBAGLU PRIOR AUTHORIZATION CRITERIA
UMC-530-0209 CARBOPLATIN (PARAPLATIN) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0011 CEREDASE PRIOR AUTHORIZATION CRITERIA
UMC-530-0011 CERDELGA PRIOR AUTHORIZATION CRITERIA
UMC-530-0011 CEREZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0061 CESAMET PRIOR AUTHORIZATION CRITERIA
UMC-530-0084 CIMZIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0076 CINRYZE PRIOR AUTHORIZATION CRITERIA
UMC-530-0120 COMETRIQ PRIOR AUTHORIZATION CRITERIA
UMC-530-0084 COSENTYX STEP THERAPY CRITERIA
UMC-530-0183 CYRAMZA PRIOR AUTHORIZATION CRITERIA
UMC-530-0168 CYSTAGON PRIOR AUTHORIZATION CRITERIA
UMC-530-0158 CYSTARAN PRIOR AUTHORIZATION CRITERIA
UMC-530-0131 DALIRESP PRIOR AUTHORIZATION CRITERIA
UMC-530-0149 DAYTRANA STEP THERAPY CRITERIA
UMC-530-0149 DESOXYN STEP THERAPY CRITERIA
UMC-530-0066 DESVENLAFAXINE STEP THERAPY CRITERIA
UMC-530-0126 DIFICID PRIOR AUTHORIZATION CRITERIA
UMC-530-0039 DIPENTUM STEP THERAPY CRITERIA
UMC-530-0208 DOCERTAXEL (TAXOTERE) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0108 DORYX PRIOR AUTHORIZATION CRITERIA
UMC-530-0108 DOXYCYCLINE HYCLATE DELAYED RELEASE TABLETS/CAPSULES PRIOR AUTHORIZATION CRITERIA
UMC-530-0115 DUEXIS STEP THERAPY CRITERIA
UMC-530-0213 DUOPA PRIOR AUTHORIZATION CRITERIA
UMC-530-0082 EDARBI STEP THERAPY CRITERIA
UMC-530-0083 EDARBYCLOR STEP THERAPY CRITERIA
UMC-530-0081 EDLUAR STEP THERAPY CRITERIA
UMC-530-0112 EGRIFTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0019 ELAPRASE PRIOR AUTHORIZATION CRITERIA
UMC-530-0011 ELELYSO PRIOR AUTHORIZATION CRITERIA 
UMC-530-0132 ELIDEL PRIOR AUTHORIZATION CRITERIA
UMC-530-0164 ELOXATIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0095 EMBEDA PRIOR AUTHORIZATION CRITERIA
UMC-530-0085 ENABLEX STEP THERAPY CRITERIA
UMC-530-0006 ENBREL PRIOR AUTHORIZATION CRITERIA
UMC-530-0084 ENTYVIO STEP THERAPY CRITERIA
UMC-530-0159 ERBITUX PRIOR AUTHORIZATION CRITERIA
UMC-530-0135 ERIVEDGE PRIOR AUTHORIZATION CRITERIA
UMC-530-0212 ESBRIET PRIOR AUTHORIZATION CRITERIA
UMC-530-0027 ESOMEPRAZOLE PRIOR AUTHORIZATION CRITERIA
UMC-530-0105 EUFLEXXA PRIOR AUTHORIZATION CRITERIA
UMC-530-0042 EXALGO STEP THERAPY CRITERIA
UMC-530-0106 EXTAVIA STEP THERAPY CRITERIA
UMC-530-0020 FABRAZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0142 FARXIGA STEP THERAPY CRITERIA
UMC-530-0217 FARYDAK PRIOR AUTHORIZATION CRITERIA
UMC-530-0047 FENTANYL TRANSMCOSAL PRIOR AUTHORIZATION CRITERIA
UMC-530-0047 FENTORA PRIOR AUTHORIZATION CRITERIA
UMC-530-0066 FETZIMA STEP THERAPY CRITERIA
UMC-530-0076 FIRAZYR PRIOR AUTHORIZATION CRITERIA
UMC-530-0149 FOCALIN XR STEP THERAPY CRITERIA
UMC-530-0015 FORTEO PRIOR AUTHORIZATION CRITERIA
UMC-530-0087 FORTESTA STEP THERAPY CRITERIA
UMC-530-0099 GAMMAGARD PRIOR AUTHORIZATION CRITERIA
UMC-530-0099 GAMMAKED PRIOR AUTHORIZATION CRITERIA
UMC-530-0099 GAMUNEX- C PRIOR AUTHORIZATION CRITERIA
UMC-530-0150 GATTEX (TEDUGLUTIDE [rDNA ORIGIN]) PRIOR AUTHORIZATION CRITERIA
UMC-530-0174 GAZYVA PRIOR AUTHORIZATION CRITERIA
UMC-530-0105 GEL-ONE PRIOR AUTHORIZATION CRITERIA
UMC-530-0160 GEMZAR PRIOR AUTHORIZATION CRITERIA
UMC-530-0039 GIAZO STEP THERAPY CRITERIA
UMC-530-0166 GILOTRIF PRIOR AUTHORIZATION CRITERIA
UMC-530-0113 GILENYA PRIOR AUTHORIZATION CRITERIA
UMC-530-0009 GLEEVEC PRIOR AUTHORIZATION CRITERIA
UMC-530-0142 GLYXAMBI STEP THERAPY CRITERIA
UMC-530-0057 GRALISE PRIOR AUTHORIZATION CRITERIA
UMC-530-0163 GRANIX PRIOR AUTHORIZATION CRITERIA
UMC-530-0182 GRASTEK PRIOR AUTHORIZATION CRITERIA
UMC-530-0012 GROWTH HORMONE PRIOR AUTHORIZATION CRITERIA
UMC-530-0117 HALAVEN PRIOR AUTHORIZATION CRITERIA
UMC-530-0211 HARVONI PRIOR AUTHORIZATION CRITERIA
UMC-530-0161 HERCEPTIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0184 HETLIOZ PRIOR AUTHORIZATION CRITERIA
UMC-530-0099 HIZENTRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0057 HORIZANT PRIOR AUTHORIZATION CRITERIA
UMC-530-0016 HUMIRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0105 HYALGAN PRIOR AUTHORIZATION CRITERIA
UMC-530-0042 HYDROMORPHONE ER STEP THERAPY CRITERIA
UMC-530-0189 HYSINGLA ER PRIOR AUTHORIZATION CRITERIA
UMC-530-0099 HYQVIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0219 IBRANCE PRIOR AUTHORIZATION CRITERIA
UMC-530-0067 ICLUSIG PRIOR AUTHORIZATION CRITERIA
UMC-530-0072 ILARIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0175 IMBRUVICA PRIOR AUTHORIZATION CRITERIA
UMC-530-0013 INCRELEX PRIOR AUTHORIZATION CRITERIA
UMC-530-0136 INLYTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0081 INTERMEZZO STEP THERAPY CRITERIA
UMC-530-0142 INVOKAMET STEP THERAPY CRITERIA
UMC-530-0142 INVOKANA STEP THERAPY CRITERIA
UMC-530-0118 IPRIVASK PRIOR AUTHORIZATION CRITERIA
UMC-530-0152 IVIG PRIOR AUTHORIZATION CRITERIA
UMC-530-0176 IXEMPRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0141 JAKAFI PRIOR AUTHORIZATION CRITERIA
UMC-530-0142 JARDIANCE STEP THERAPY CRITERIA
UMC-530-0148 JUXTAPID PRIOR AUTHORIZATION CRITERIA
UMC-530-0153 KADCYLA PRIOR AUTHORIZATION CRITERIA
UMC-530-0076 KALBITOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0134 KALYDECO PRIOR AUTHORIZATION CRITERIA
UMC-530-0058 KAZANO STEP THERAPY CRITERIA
UMC-530-0202 KEYTRUDA PRIOR AUTHORIZATION CRITERIA
UMC-530-0066 KHEDELZA STEP THERAPY CRITERIA
UMC-530-0023 KINERET PRIOR AUTHORIZATION CRITERIA
UMC-530-0058 KOMBIGLYZE XR STEP THERAPY CRITERIA
UMC-530-0139 KORLYM PRIOR AUTHORIZATION CRITERIA
UMC-530-0114 KRYSTEXXA PRIOR AUTHORIZATION CRITERIA
UMC-530-0148 KYNAMRO PRIOR AUTHORIZATION CRITERIA
UMC-530-0143 KYPROLIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0027 LANSOPRAZOLE STEP THERAPY CRITERIA
UMC-530-0047 LAZANDA PRIOR AUTHORIZATION CRITERIA
UMC-530-0220 LENVIMA PRIOR AUTHORIZATION CRITERIA
UMC-530-0038 LESCOL XL STEP THERAPY CRITERIA
UMC-530-0065 LETAIRIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0030 LEUPROLIDE INJECTION PRIOR AUTHORIZATION CRITERIA
UMC-530-0038 LIVALO STEP THERAPY CRITERIA
UMC-530-0127 LUMIGAN STEP THERAPY CRITERIA
UMC-530-0100 LUMIZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0218 LYNPARZA PRIOR AUTHORIZATION CRITERIA
UMC-530-0057 LYRICA STEP THERAPY & PRIOR AUTHORIZATION CRITERIA
UMC-530-0046 MAXAIR STEP THERAPY CRITERIA
UMC-530-0119 MAKENA PRIOR AUTHORIZATION CRITERIA
UMC-530-0146 MARQIBO PRIOR AUTHORIZATION CRITERIA
UMC-530-0167 MEKINIST PRIOR AUTHORIZATION CRITERIA
UMC-530-0149 METHYLIN STEP THERAPY CRITERIA
UMC-530-0071 MINILINK TRANSMITTER-SENSOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0108 MINOCYCLINE HCl ER PRIOR AUTHORIZATION CRITERIA
UMC-530-0108 MONODOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0105 MONOVISC PRIOR AUTHORIZATION CRITERIA
UMC-530-0108 MORGIDOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0185 MYALEPT PRIOR AUTHORIZATION CRITERIA
UMC-530-0100 MYOZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0053 NAGLAZYME PRIOR AUTHORIZATION CRITERIA
UMC-530-0115 NALFON STEP THERAPY CRITERIA
UMC-530-0115 NAPRELAN STEP THERAPY CRITERIA
UMC-530-0222 NATPARA PRIOR AUTHORIZATION CRITERIA
UMC-530-0058 NESINA STEP THERAPY CRITERIA
UMC-530-0163 NEULASTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0163 NEUPOGEN PRIOR AUTHORIZATION CRITERIA
UMC-530-0027 NEXIUM STEP THERAPY CRITERIA
UMC-530-0221 NORTHERA PRIOR AUTHORIZATION CRITERIA
UMC-530-0116 NUEDEXTA PRIOR AUTHORIZATION CRITERIA
UMC-530-0108 OCUDOX PRIOR AUTHORIZATION CRITERIA
UMC-530-0212 OFEV PRIOR AUTHORIZATION CRITERIA
UMC-530-0124 OLYSIO PRIOR AUTHORIZATION CRITERIA
UMC-530-0044 OMNARIS STEP THERAPY CRITERIA
UMC-530-0133 ONEXTON PRIOR AUTHORIZATION CRITERIA
UMC-530-0058 ONGLYZA STEP THERAPY CRITERIA
UMC-530-0004 ONMEL (ITRACONAZOLE) PRIOR AUTHORIZATION
UMC-530-0047 ONSOLIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0042 OPANA ER STEP THERAPY CRITERIA 
UMC-530-0202 OPDIVO PRIOR AUTHORIZATION CRITERIA
UMC-530-0065 OPSUMIT PRIOR AUTHORIZATION AND STEP THERAPY CRITERIA
UMC-530-0108 ORACEA PRIOR AUTHORIZATION CRITERIA
UMC-530-0182 ORALAIR PRIOR AUTHORIZATION CRITERIA
UMC-530-0107 ORAVIG STEP THERAPY CRITERIA
UMC-530-0084 ORENCIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0186 ORENITRAM PRIOR AUTHORIZATION CRITERIA
UMC-530-0024 ORFADIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0134 ORKAMBI PRIOR AUTHORIZATION CRITERIA
UMC-530-0105 ORTHOVISC PRIOR AUTHORIZATION CRITERIA
UMC-530-0058 OSENI STEP THERAPY CRITERIA
UMC-530-0084 OTEZLA STEP THERAPY CRITERIA
UMC-530-0187 OTREXUP PRIOR AUTHORIZATON CRITERIA
UMC-530-0022 OXANDRIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0042 OXYMORPHONE ER STEP THERAPY CRITERIA
UMC-530-0207 PACLITAXEL (TAXOL) UTILIZATION MANAGEMENT CRITERIA
UMC-530-0008 PEGASYS PRIOR AUTHORIZATION CRITERIA
UMC-530-0138 PERJETA PRIOR AUTHORIZATION CRITERIA
UMC-530-0106 PLEGRIDY STEP THERAPY CRITERIA
UMC-530-0154 POMALYST PRIOR AUTHORIZATION CRITERIA
UMC-530-0027 PREVACID SOLUTABS STEP THERAPY CRITERIA
UMC-530-0027 PRILOSEC SUSPENSION PACKET STEP THERAPY CRITERIA
UMC-530-0066 PRISTIQ PRIOR AUTHORIZATION/STEP THERAPY CRITERIA
UMC-530-0149 PROCENTRA ORAL SOLUTION STEP THERAPY CRITERIA
UMC-530-0168 PROCYSBI PRIOR AUTHORIZATION CRITERIA
UMC-530-0111 PROLASTIN-C STEP THERAPY CRITERIA
UMC-530-0097 PROLIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0132 PROTOPIC PRIOR AUTHORIZATION CRITERIA
UMC-530-0046 PROVENTIL HFA STEP THERAPY CRITERIA
UMC-530-0044 QNASL CHILDRENS STEP THERAPY CRITERIA
UMC-530-0044 QNASL STEP THERAPY CRITERIA
UMC-530-0149 QUILLIVANT XR ORAL SUSPENSION STEP THERAPY CRITERIA
UMC-530-0045 Q-VAR STEP THERAPY CRITERIA
UMC-530-0182 RAGWITEK PRIOR AUTHORIZATION CRITERIA
UMC-530-0210 RALOXIFENE AT ZERO COPAY PRIOR AUTHORIZATION
UMC-530-0214 RAVICTI PRIOR AUTHORIZATION CRITERIA
UMC-530-0156 RAYOS PRIOR AUTHORIZATION CRITERIA
UMC-530-0069 RECLAST PRIOR AUTHORIZATION CRITERIA
UMC-530-0075 RELISTOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0084 REMICADE PRIOR AUTHORIZATION CRITERIA
UMC-530-0155 REVLIMID PRIOR AUTHORIZATION CRITERIA
UMC-530-0165 RITUXAN PRIOR AUTHORIZATION CRITERIA
UMC-530-0056 RUCONEST PRIOR AUTHORIZATION CRITERIA
UMC-530-0090 SAMSCA PRIOR AUTHORIZATION CRITERIA
UMC-530-0036 SANCUSO STEP THERAPY CRITERIA
UMC-530-0081 SILENOR STEP THERAPY CRITERIA
UMC-530-0084 SIMPONI PRIOR AUTHORIZATION CRITERIA
UMC-530-0108 SOLODYN PRIOR AUTHORIZATION CRITERIA
UMC-530-0021 SOMAVERT PRIOR AUTHORIZATION CRITERIA
UMC-530-0177 SOVALDI PRIOR AUTHORIZATION CRITERIA
UMC-530-0115 SPRIX STEP THERAPY CRITERIA
UMC-530-0067 SPRYCEL PRIOR AUTHORIZATION CRITERIA
UMC-530-0084 STELARA PRIOR AUTHORIZATION CRITERIA
UMC-530-0144 STIVARGA PRIOR AUTHORIZATION CRITERIA
UMC-530-0172 SUBOXONE AND SUBUTEX PRIOR AUTHORIZATION CRITERIA
UMC-530-0047 SUBSYS PRIOR AUTHORIZATION CRITERIA
UMC-530-0105 SUPARTZ PRIOR AUTHORIZATION CRITERIA
UMC-530-0204 SUTENT PRIOR AUTHORIZATION CRITERIA
UMC-530-0123 SYLATRON PRIOR AUTHORIZATION CRITERIA
UMC-530-0188 SYLVANT PRIOR AUTHORIZATION CRITERIA
UMC-530-0051 SYMLIN PRIOR AUTHORIZATION CRITERIA
UMC-530-0005 SYNAGIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0151 SYNRIBO PRIOR AUTHORIZATION CRITERIA
UMC-530-0105 SYNVISC-ONE PRIOR AUTHORIZATION CRITERIA
UMC-530-0105 SYNVISC PRIOR AUTHORIZATION CRITERIA
UMC-530-0169 TAFINLAR PRIOR AUTHORIZATION CRITERIA
UMC-530-0210 TAMOXIFEN AT ZERO COPAY PRIOR AUTHORIZATION
UMC-530-0052 TANZEUM STEP THERAPY CRITERIA
UMC-530-0067 TASIGNA PRIOR AUTHORIZATION CRITERIA
UMC-530-0113 TECFIDERA PRIOR AUTHORIZATION CRITERIA
UMC-530-0068 TEKTURNA/TEKTURNA HCT STEP THERAPY CRITERIA
UMC-530-0087 TESTIM STEP THERAPY CRITERIA
UMC-530-0087 TESTOSTERONE STEP THERAPY CRITERIA
UMC-530-0083 TEVETEN HCT STEP THERAPY CRITERIA
UMC-530-0115 TIVORBEX STEP THERAPY CRITERIA
UMC-530-0085 TOVIAZ STEP THERAPY CRITERIA
UMC-530-0065 TRACLEER PRIOR AUTHORIZATION CRITERIA
UMC-530-0127 TRAVATAN-Z STEP THERAPY CRITERIA
UMC-530-0178 TREANDA PRIOR AUTHORIZATION CRITERIA
UMC-530-0052 TRULICITY STEP THERAPY CRITERIA
UMC-530-0062 TYKERB PRIOR AUTHORIZATION CRITERIA
UMC-530-0074 TYSABRI PRIOR AUTHORIZATION CRITERIA
UMC-530-0064 TYVASO PRIOR AUTHORIZATION CRITERIA
UMC-530-0068 VALTURNA STEP THERAPY CRITERIA
UMC-530-0179 VALCHLOR PRIOR AUTHORIZATION CRITERIA
UMC-530-0171 VELCADE PRIOR AUTHORIZATION CRITERIA
UMC-530-0133 VELTIN STEP THERAPY CRITERIA
UMC-530-0064 VENTAVIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0044 VERAMYST STEP THERAPY CRITERIA
UMC-530-0124 VICTRELIS PRIOR AUTHORIZATION CRITERIA
UMC-530-0054 VIIBRYD STEP THERAPY CRITERIA
UMC-530-0137 V-GO DISPOSABLE INSULIN DELIVERY PRIOR AUTHORIZATION CRITERIA
UMC-530-0052 VICTOZA STEP THERAPY CRITERIA
UMC-530-0211 VIEKIRA PRIOR AUTHORIZATION CRITERIA
UMC-530-0180 VIMIZIM PRIOR AUTHORIZATION CRITERIA
UMC-530-0077 VIMOVO STEP THERAPY CRITERIA
UMC-530-0087 VOGELXO STEP THERAPY CRITERIA
UMC-530-0140 VOTRIENT PRIOR AUTHORIZATION CRITERIA
UMC-530-0011 VPRIV PRIOR AUTHORIZATION CRITERIA
UMC-530-0149 VYVANSE STEP THERAPY CRITERIA
UMC-530-0128 XALKORI PRIOR AUTHORIZATION CRITERIA
UMC -530-0084 XELJANZ PRIOR AUTHORIZATION CRITERIA
UMC -530-0086 XENAZINE PRIOR AUTHORIZATION CRITERIA
UMC -530-0097 XGEVA PRIOR AUTHORIZATION CRITERIA
UMC-530-0142 XIGDUO XR STEP THERAPY CRITERIA
UMC-530-0032 XOLAIR PRIOR AUTHORIZATION CRITERIA
UMC-530-0121 XTANDI PRIOR AUTHORIZATION CRITERIA
UMC-530-0215 XYREM PRIOR AUTHORIZATION CRITERIA
UMC-530-0122 YERVOY PRIOR AUTHORIZATION CRITERIA
UMC-530-0145 ZALTRAP PRIOR AUTHORIZATION CRITERIA
UMC-530-0034 ZAVESCA PRIOR AUTHORIZATION CRITERIA
UMC-530-0027 ZEGERID STEP THERAPY CRITERIA
UMC-530-0129 ZELBORAF PRIOR AUTHORIZATION CRITERIA
UMC-530-0149 ZENZEDI STEP THERAPY CRITERIA
UMC-530-0044 ZETONNA STEP THERAPY CRITERIA
UMC-530-0133 ZIANA STEP THERAPY CRITERIA
UMC-530-0127 ZIOPTAN STEP THERAPY CRITERIA
UMC-530-0115 ZIPSOR STEP THERAPY CRITERIA
UMC-530-0189 ZOHYDRO ER PRIOR AUTHORIZATION CRITERIA
UMC-530-0059 ZOLINZA PRIOR AUTHORIZATION CRITERIA
UMC -530-0081 ZOLPIMIST STEP THERAPY CRITERIA
UMC-530-0069 ZOMETA PRIOR AUTHORIZATION CRITERIA
UMC-530-0115 ZORVOLEX STEP THERAPY CRITERIA
UMC-530-0036 ZUPLENZ FILMSTRIPS STEP THERAPY CRITERIA
UMC-530-0203 ZYDELIG PRIOR AUTHORIZATION CRITERIA
UMC-530-0190 ZYKADIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0121 ZYTIGA PRIOR AUTHORIZATION CRITERIA
 

By Drug Class:

UMC-530-0036 5HT3 RECEPTOR ANTAGONIST ANTI-EMETICS STEP THERAPY CRITERIA
UMC-530-0133 ACNE COMBINATION STEP THERAPY CRITERIA
UMC-530-0182 ALLERGY IMMUNOTHERAPY, SUBLINGUAL PRIOR AUTHORIZATION CRITERIA
UMC-530-0111 ALPHA1 PROTEINASE INHIBITOR (HUMAN) STEP THERAPY CRITERIA
UMC-530-0022 ANABOLIC STEROIDS PRIOR AUTHORIZATION CRITERIA
UMC-530-0083 ANGIOTENSIN II RECEPTOR ANTAGONIST/ HYDROCHLOROTHIAZIDE COMBINATION STEP THERAPY CRITERIA
UMC-530-0082 ANGIOTENSIN II RECEPTOR ANTAGONIST STEP THERAPY CRITERIA
UMC-530-0078 BLOOD GLUCOSE TEST STRIP PRIOR AUTHORIZATION CRITERIA
UMC-530-0046 BRONCHODILATOR SHORT ACTING PT STEP THERAPY CRITERIA
UMC-530-0149 CENTRAL NERVOUS STIMULANTS (CNS) FOR ATTENTION DEFICIT/HYPERACTIVITY (ADHD) STEP THERAPY CRITERIA
UMC-530-0071 CONTINUOUS GLUCOSE MONITORS AND SENSORS PRIOR AUTHORIZATION CRITERIA
UMC-530-0001 CONTRACEPTIVES PRIOR AUTHORIZATION CRITERIA
UMC-530-0108 DOXYCYCLINE/MINOCYCLINE EXTENDED RELEASE PRODUCTS PRIOR AUTHORIZATION CRITERIA
UMC-530-0058 DPP IV INHIBITORS STEP THERAPY CRITERIA
UMC-530-0065 ENDOTHELIN-RECEPTOR ANTAGONISTS PRIOR AUTHORIZATION CRITERIA
UMC-530-0070 EXEMPT INFANT FORMULAS PRIOR AUTHORIZATION CRITERIA
UMC-530-0029 FERTILITY INJECTIBLE MEDICATION PRIOR AUTHORIZATION CRITERIA
UMC-530-0011 GAUCHER DISEASE MEDICATION PRIOR AUTHORIZATION CRITERIA
UMC-530-0052 GLP-1 RECEPTOR AGONISTS STEP THERAPY CRITERIA
UMC-530-0211 HEPATITIS C MEDICATIONS PRIOR AUTHORIZATION CRITERIA
UMC-530-0076 HEREDITARY ANGIOEDEMA (HAE) MEDICATIONS PRIOR AUTHORIZATION CRITERIA
UMC-530-0038 HMGs (STATINS) STEP THERAPY CRITERIA
UMC-530-0105 HYALURONIC ACID DERIVATIVES PRIOR AUTHORIZATION CRITERIA
UMC-530-0212 IDIOPATHIC PULMONARY FIBROSIS (IPF) MEDICATIONS PRIOR AUTHORIZATION CRITERIA
UMC-530-0099 IMMUNE GLOBULIN SUBCUTANEOUS, PRIOR AUTHORIZATION CRITERIA
UMC-530-0049 IMMUNIZATIONS POLICY
UMC-530-0084 IMMUNOMODULATORS IN THE TREATMENT OF INFLAMMATORY DISEASE PRIOR AUTHORIZATION CRITERIA
UMC-530-0039 INFLAMMATORY BOWEL MEDICATIONS STEP THERAPY
UMC-530-0067 KINASE INHIBITORS FOR LEUKEMIA PRIOR AUTHORIZATION CRITERIA
UMC-530-0120 KINASE INHIBITORS IN THE TREATMENT OF MEDULLARY THYROID CANCER PRIOR AUTHORIZATION CRITERIA
UMC-530-0042 LONG -ACTING NARCOTIC ANALGESICS
UMC-530-0033 LYME DISEASE PRIOR AUTHORIZATION CRITERIA
UMC-530-0113 MULTIPLE SCLEROSIS DISEASE ORAL MODIFYING AGENTS PRIOR AUTHORIZATION CRITERIA
UMC-530-0106 MULTIPLE SCLEROSIS SELF-ADMINISTERED INJECTABLES STEP THERAPY CRITERIA
UMC-530-0044 NASAL CORTICOSTEROIDS STEP THERAPY CRITERIA
UMC-530-0115 NSAID STEP THERAPY CRITERIA
UMC-530-0127 OPHTHALMIC PROSTAGLANDIN AGONISTS STEP THERAPY CRITERIA
UMC-530-0085 OVERACTIVE BLADDER MEDICATIONS STEP THERAPY CRITERIA
UMC-530-0008 PEGYLATED INTERFERON ALPHA PRIOR AUTHORIZATION CRITERIA
UMC-530-0124 PROTEASE INHIBITORS IN THE TREATMENT OF HEPATITIS C PRIOR AUTHORIZATION CRITERIA
UMC-530-0027 PROTON PUMP INHIBITORS STEP THERAPY CRITERIA
UMC-530-0045 PULMONARY ANTI-INFLAMMATORIES STEP THERAPY CRITERIA
UMC-530-0081 SEDATIVE/HYPNOTIC STEP THERAPY CRITERIA
UMC-530-0066 SNRI STEP THERAPY CRITERIA
UMC-530-0054 SSRI STEP THERAPY CRITERIA
UMC-530-0038 STATINS STEP THERAPY CRITERIA
UMC-530-0087 TESTOSTERONE-TOPICAL STEP THERAPY CRITERIA
UMC-530-0214 UREA CYCLE DISORDERS MEDICATIONS PRIOR AUTHORIZATION CRITERIA
UMC-530-0069 ZOLEDRONIC ACID (RECLAST/ZOMETA) INFUSION PRIOR AUTHORIZATION CRITERIA